These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 10513218
1. [The relationship between the histopathological atypia and expression of beta-catenin in colonic neoplasms resected by endoscopy; comparison with that of p53 protein]. Shimizu M, Yoshimi N, Shimizu S, Shimojyo H, Ninomiya M, Moriwaki H. Nihon Shokakibyo Gakkai Zasshi; 1999 Sep; 96(9):1050-6. PubMed ID: 10513218 [Abstract] [Full Text] [Related]
2. P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Walsh SV, Loda M, Torres CM, Antonioli D, Odze RD. Am J Surg Pathol; 1999 Aug; 23(8):963-9. PubMed ID: 10435567 [Abstract] [Full Text] [Related]
3. Intracellular distribution of beta-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps. Herter P, Kuhnen C, Müller KM, Wittinghofer A, Müller O. J Cancer Res Clin Oncol; 1999 Aug; 125(5):297-304. PubMed ID: 10359135 [Abstract] [Full Text] [Related]
4. Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong. Wong SC, Lo ES, Chan AK, Lee KC, Hsiao WL. Mol Pathol; 2003 Dec; 56(6):347-52. PubMed ID: 14645698 [Abstract] [Full Text] [Related]
5. The significance of beta-catenin, E-cadherin, and P-cadherin expressions in neoplastic progression of colorectal mucosa: an immunohistochemical study. Savas B, Ensari A, Percinel S, Kuzu I, Kuzu MA, Bektas M, Cetinkaya H, Kursun N. Acta Gastroenterol Belg; 2007 Dec; 70(4):339-44. PubMed ID: 18330089 [Abstract] [Full Text] [Related]
6. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Oh K, Redston M, Odze RD. Hum Pathol; 2005 Jan; 36(1):101-11. PubMed ID: 15712188 [Abstract] [Full Text] [Related]
7. [Expression of CD10 in tumor-associated fibroblast of cancerized or recurrent colorectal adenomas]. Zheng J, Zhu Y, Li C, Li Y, Nie Q, Zhu Z, Deng H. Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May 25; 45(4):335-341. PubMed ID: 27868405 [Abstract] [Full Text] [Related]
8. Dysregulation of beta-catenin is common in canine sporadic colorectal tumors. McEntee MF, Brenneman KA. Vet Pathol; 1999 May 25; 36(3):228-36. PubMed ID: 10332831 [Abstract] [Full Text] [Related]
9. Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer. Garcia del Muro X, Torregrosa A, Muñoz J, Castellsagué X, Condom E, Vigués F, Arance A, Fabra A, Germà JR. Eur J Cancer; 2000 Feb 25; 36(3):357-62. PubMed ID: 10708937 [Abstract] [Full Text] [Related]
10. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma. Hao X, Palazzo JP, Ilyas M, Tomlinson I, Talbot IC. Anticancer Res; 1997 Feb 25; 17(3C):2241-7. PubMed ID: 9216695 [Abstract] [Full Text] [Related]
11. P53 and beta-catenin in colorectal cancer progression. Valentini AM, Pirrelli M, Renna L, Armentano R, Caruso ML. Curr Pharm Des; 2003 Feb 25; 9(24):1932-6. PubMed ID: 12871177 [Abstract] [Full Text] [Related]
12. p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma. Yao T, Utsunomiya T, Nagai E, Oya M, Tsuneyoshi M. Pathol Int; 1996 Dec 25; 46(12):962-7. PubMed ID: 9110348 [Abstract] [Full Text] [Related]
13. E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression. Jungck M, Grünhage F, Spengler U, Dernac A, Mathiak M, Caspari R, Friedl W, Sauerbruch T. Int J Colorectal Dis; 2004 Sep 25; 19(5):438-45. PubMed ID: 14986031 [Abstract] [Full Text] [Related]
14. Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues. Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH. Carcinogenesis; 2000 Nov 25; 21(11):1935-40. PubMed ID: 11062151 [Abstract] [Full Text] [Related]
15. Sessile serrated adenomas of the large bowel. Clinicopathologic and immunohistochemical study including comparison with common hyperplastic polyps and adenomas. Chlumská A, Boudová L, Zámecník M. Cesk Patol; 2006 Jul 25; 42(3):133-8. PubMed ID: 16955561 [Abstract] [Full Text] [Related]
16. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. Resnick MB, Routhier J, Konkin T, Sabo E, Pricolo VE. Clin Cancer Res; 2004 May 01; 10(9):3069-75. PubMed ID: 15131045 [Abstract] [Full Text] [Related]
17. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder. Takei K, Watanabe H, Itoi T, Saito T. Pathol Int; 1996 Nov 01; 46(11):908-17. PubMed ID: 8970203 [Abstract] [Full Text] [Related]
18. Immunohistochemical analysis of p53 overexpression in human colonic tumors. Darmon E, Cleary KR, Wargovich MJ. Cancer Detect Prev; 1994 Nov 01; 18(3):187-95. PubMed ID: 8076381 [Abstract] [Full Text] [Related]
19. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis. Keller JJ, Offerhaus GJ, Drillenburg P, Caspers E, Musler A, Ristimäki A, Giardiello FM. Clin Cancer Res; 2001 Dec 01; 7(12):4000-7. PubMed ID: 11751493 [Abstract] [Full Text] [Related]
20. Correlation of beta-catenin and cyclin D1 expression in colon cancers. Utsunomiya T, Doki Y, Takemoto H, Shiozaki H, Yano M, Sekimoto M, Tamura S, Yasuda T, Fujiwara Y, Monden M. Oncology; 2001 Dec 01; 61(3):226-33. PubMed ID: 11574779 [Abstract] [Full Text] [Related] Page: [Next] [New Search]